Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2023 Jul 28;31(8):496.
doi: 10.1007/s00520-023-07962-6.

Comorbidity burden and health-related quality of life in men with advanced prostate cancer

Affiliations
Observational Study

Comorbidity burden and health-related quality of life in men with advanced prostate cancer

Roberto M Benzo et al. Support Care Cancer. .

Abstract

Purpose: Identifying clinically relevant comorbidities and their effect on health-related quality of life (HRQoL) outcomes among men with advanced prostate cancer (APC) can inform patient care and improve outcomes; however, this is poorly understood. The aim of this observational study was to examine the prevalence of comorbidities, and the relationship of comorbidity burden to HRQoL and other patient-reported outcomes (PROs) among men with APC.

Methods: Participants were 192 men (average age 68.8) with APC (stage III or IV) who completed a psychosocial battery including measures of sociodemographic factors, HRQoL and other PROs, and the Charlson Comorbidity Index (CCI). Hierarchical multiple regression analysis was used to examine the relationships between CCI, HRQOL, and PROs.

Results: The vast majority (82%) of participants had at least one comorbidity, with the most common being: hypertension (59%), connective tissue disease or arthritis (31%), diabetes (24%), and problems with kidneys, vision, or another organ (24%). After controlling for covariates, regressions showed that a higher CCI score was significantly associated with worse HRQoL (p < 0.001), lower levels of positive affect (p < 0.05), and higher levels of depression (p < 0.05), fatigue (p < 0.001), pain (p < 0.01), stress (p < 0.01), and cancer-specific distress (p < 0.05).

Conclusions: Comorbidities were common among men with APC, and a greater CCI score was associated with detriments in several domains of HRQoL and other PROs. Our findings show the need to address comorbidities in the presence of a cancer diagnosis and subsequent treatment. TRIAL REGISTRATION CLINICALTRIALS.

Gov identifier: NCT03149185.

Keywords: Cancer; Comorbidity; Oncology; Patient Reported Outcome Measures; Prostatic Neoplasms; Quality of Life.

PubMed Disclaimer

Conflict of interest statement

Competing Interests. The authors have no conflicts of interest to disclose.

Update of

References

    1. Surveillance Epidemiology and End Results (SEER) Program, SEER*Stat Database: Incidence - SEER Research Data, 9 Registries, in Nov 2019 Sub (1975–2017). 2019, National Cancer Institute.
    1. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database,, Cancer Stat Facts: Prostate Cancer. 2017–2018, National Cancer Institute (NCI),: Online.
    1. Droz JP, et al., Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology. BJU Int, 2010. 106(4): p. 462–9. - PMC - PubMed
    1. Michaelson MD, et al., Management of complications of prostate cancer treatment. CA Cancer J Clin, 2008. 58(4): p. 196–213. - PMC - PubMed
    1. Spratt DE, et al., Treating the patient and not just the cancer: therapeutic burden in prostate cancer. Prostate Cancer and Prostatic Diseases, 2021. 24(3): p. 647–661. - PMC - PubMed

Publication types

Associated data